India Continuous Subcutaneous Insulin Infusion Market Size & Outlook
Related Markets
India continuous subcutaneous insulin infusion market highlights
- The India continuous subcutaneous insulin infusion market generated a revenue of USD 16.4 million in 2024 and is expected to reach USD 29.1 million by 2030.
- The India market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
- In terms of segment, tethered pumps was the largest revenue generating product in 2024.
- Patch Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Continuous subcutaneous insulin infusion market data book summary
| Market revenue in 2024 | USD 16.4 million |
| Market revenue in 2030 | USD 29.1 million |
| Growth rate | 9.8% (CAGR from 2025 to 2030) |
| Largest segment | Tethered pumps |
| Fastest growing segment | Patch Pumps |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Patch Pumps, Tethered Pumps |
Other key industry trends
- In terms of revenue, India accounted for 2.4% of the global continuous subcutaneous insulin infusion market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China continuous subcutaneous insulin infusion market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 51.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Continuous Subcutaneous Insulin Infusion Market Scope
Continuous Subcutaneous Insulin Infusion Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Becton, Dickinson & Company | View profile | - | - | - |
| Zealand Pharma A/S | View profile | 270 | Sydmarken 11, Soborg, Denmark, DK-2860 | https://www.zealandpharma.com |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | http://www.bbraunusa.com |
| CeQur Simplicity | View profile | 51-100 | Horw, Luzern, Switzerland, Europe | https://myceqursimplicity.com |
| Insulet Corp | View profile | 3000 | 100 Nagog Park, Acton, MA, United States, 01720 | https://www.insulet.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
India continuous subcutaneous insulin infusion market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous subcutaneous insulin infusion market will help companies and investors design strategic landscapes.
Tethered pumps was the largest segment with a revenue share of 85.98% in 2024. Horizon Databook has segmented the India continuous subcutaneous insulin infusion market based on patch pumps, tethered pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to India continuous subcutaneous insulin infusion market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India continuous subcutaneous insulin infusion market databook
-
Our clientele includes a mix of continuous subcutaneous insulin infusion market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India continuous subcutaneous insulin infusion market , including forecasts for subscribers. This country databook contains high-level insights into India continuous subcutaneous insulin infusion market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India continuous subcutaneous insulin infusion market size, by product, 2018-2030 (US$M)
India Continuous Subcutaneous Insulin Infusion Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
